During this live webinar, Dr. Kazlauskas discusses how anti-VEGF agents provide benefit by temporarily reducing the level of VEGF and overcoming vascular permeability as well as the variable patient response to VEGF.
Lecturer: Dr. Andrius Kazlauskas, University of Illinois Eye & Ear Infirmary, Chicago, USA